π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study is a placebo-controlled study in patients with Type 2 Diabetes M...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02
Trial ID
NCT00354536
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter, 4-para...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01098461
Treatments Being Tested
The incidence of Type 2 Diabetes Mellitus (T2DM) is increasing day by day b...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2017-08-14
Trial ID
NCT03015519
Treatments Being Tested
This study is an open-label study in healthy volunteers and in patients wit...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-16
Trial ID
NCT00394030
Treatments Being Tested
This study is designed to examine the efficacy and safety of 2 dose levels ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02
Trial ID
NCT01733758
Treatments Being Tested
This study will be an open-label study to evaluate the effect of albiglutid...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-03-15
Trial ID
NCT01077505
Treatments Being Tested
This study is designed to examine the long term safety and efficacy of week...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-23
Trial ID
NCT01777282
Treatments Being Tested
This study will use scintigraphy techniques to measure gastric emptying rat...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-12-07
Trial ID
NCT00537719
Albiglutide (Alb) is a novel analogue of glucagon-like peptide-1 (GLP-1) ha...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02
Trial ID
NCT02660736
The first part of the study includes a single dose treatment period to eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07
Trial ID
NCT01357889
Treatments Being Tested